Twist Bioscience Corp (NASDAQ:TWST)
| 52.95 Delayed Data As of Aug 12 |  +3.87 / +7.89%Today’s Change | 25.07 Today|||52-Week Range 139.99 | -31.58% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $3.0B |
Company Description
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.
Contact Information
Twist Bioscience Corp. 681 Gateway Boulevard San Francisco California 94080 |
Employees
Chart unavailable
Shareholders
| Mutual fund holders | 67.93% |
| Other institutional | 34.01% |
| Individual stakeholders | 13.49% |
Top Executives
| Emily Marine Leproust | Chairman, President & Chief Executive Officer |
| Tracey Mullen | Senior Vice President-Operations |
| James M. Thorburn | Chief Financial Officer |
| Siyuan Chen | Chief Technology Officer |
| Nimisha Srivastava | Senior Vice President-Research & Development |
